Severe lactic acidosis induced by nucleoside analogues in an HIV-infected man

被引：24
|
作者：
Roy, PM [1 ]
Gouello, JP [1 ]
Pennison-Besnier, I [1 ]
Chennebault, JM [1 ]
机构：
[1] Univ Hosp, Dept Emergency Med, Angers, France
来源：
ANNALS OF EMERGENCY MEDICINE | 1999年 / 34卷 / 02期
关键词：
D O I：
10.1016/S0196-0644(99)70244-1
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
Nucleoside analogues can induce myopathy or hepatitis by means of mitochondrial dysfunction. We report the case of a 31-year-old man infected with HIV who had a severe lactic acidosis without muscle or liver symptoms. He improved after hemodialysis and withdrawal of antiviral drugs. Muscle and liver evaluation allowed us to ascribe lactic acidosis to a mitochondriopathy induced by zidovudine and didanosine.
引用
收藏
页码：282 / 284
页数：3
相关论文
共 50 条
  • [21] Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients
    Levin, MJ
    Bacon, TH
    Leary, JJ
    CLINICAL INFECTIOUS DISEASES, 2004, 39 : S248 - S257
  • [22] Nucleoside analogues toxicities related to mitochondrial dysfunction:: focus on HIV-infected children
    Viganó, A
    Giacomet, V
    ANTIVIRAL THERAPY, 2005, 10 : M53 - M64
  • [23] Reexposure to nucleoside analogues after lactic acidosis/hyperlactataemia syndrome
    Galera, C
    Redondo, C
    Poza, G
    Bermejo, M
    Aroca, P
    Sánchez, A
    ANTIVIRAL THERAPY, 2004, 9 (06) : L49 - L49
  • [24] Prevalence of genotypic resistance to nucleoside analogues, non-nucleoside analogues and protease inhibitors in HIV-infected persons in Athens, Greece
    Panos, G.
    Charatsis, G.
    Paparizos, V.
    Kazantzi, M.
    Falagas, M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S665 - S665
  • [25] Risk factors for lactic acidosis in HIV-infected patients treated with nucleoside reverse-transcriptase inhibitors:: A case-control study
    Bonnet, F
    Bonarek, M
    Morlat, P
    Mercié, P
    Dupon, M
    Gemain, MC
    Malvy, D
    Bernard, N
    Pellegrin, JL
    Beylot, J
    CLINICAL INFECTIOUS DISEASES, 2003, 36 (10) : 1324 - 1328
  • [26] Lactic acidosis during nucleoside antiretroviral HIV therapy
    Khater, FJ
    Youssef, S
    Iskandar, SB
    Myers, JW
    Moorman, JP
    SOUTHERN MEDICAL JOURNAL, 2004, 97 (02) : 208 - 208
  • [27] Metabolic acidosis in HIV-infected patients
    Bonnet, F
    Bonarek, M
    Abrij, A
    Beylot, J
    Morlat, P
    CLINICAL INFECTIOUS DISEASES, 2002, 34 (09) : 1289 - 1290
  • [28] SEVERE OSTEOPOROSIS IN A YOUNG HIV-INFECTED MAN TREATED WITH TERIPATIDE
    Marocco, R.
    Del Borgo, C.
    Cesareo, R.
    Mercurio, V. S.
    Belvisi, V.
    Lichtner, M.
    Mastroianni, C. M.
    INFECTION, 2011, 39 : S84 - S84
  • [29] Primary genotypic resistance to nucleoside analogues in naive HIV-infected patients in Andalusia (Spain)
    Kindelan, JM
    Vidal, E
    Madueño, J
    Gimenez-Domenech, R
    Viciana, P
    Causse, M
    Baron, B
    Marquez, M
    Gómez-Mateos, J
    Pérez-Cortes, S
    Pasquau, J
    Vergara, A
    Rodriguez-Baño, J
    Pérez-Guzman, E
    Merino, D
    SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, : 37 - 41
  • [30] L-carnitine as a treatment of life-threatening lactic acidosis induced by nucleoside analogues
    Claessens, YE
    Chariou, A
    Chiche, JD
    Dauriat, G
    Dhainaut, JF
    AIDS, 2000, 14 (04) : 472 - 473
12345